A comparison of monoclonal antibodies against murine PD-1 and PD-L1

被引：0
|
作者：
Bu, Melissa Tian
Yuan, Long
Klee, Alyssa
Freeman, Gordon J.
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2022年 / 208卷 / 01期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.4049/jimmunol.208.Supp.176.05
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
176.05
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-1 and PD-L1 prognostic in UTUC
    Stone, Louise
    NATURE REVIEWS UROLOGY, 2017, 14 (09) : 518 - 518
  • [22] PD-1 and PD-L1 prognostic in UTUC
    Louise Stone
    Nature Reviews Urology, 2017, 14 : 518 - 518
  • [23] A snapshot of the PD-1/PD-L1 pathway
    Ghosh, Chinmoy
    Luong, Gary
    Sun, Yue
    JOURNAL OF CANCER, 2021, 12 (09): : 2735 - 2746
  • [24] PD-1/PD-L1 in cardiovascular disease
    Sun, YunFeng
    Li, Liang
    Wu, YaWei
    Yang, KePing
    CLINICA CHIMICA ACTA, 2020, 505 : 26 - 30
  • [25] Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function
    Choi, Jin Wook
    Withers, Sita S.
    Chang, Hong
    Spanier, Justin A.
    De La Trinidad, Victoria L.
    Panesar, Harmanpreet
    Fife, Brian T.
    Sciammas, Roger
    Sparger, Ellen E.
    Moore, Peter F.
    Kent, Michael S.
    Rebhun, Robert B.
    McSorley, Stephen J.
    PLOS ONE, 2020, 15 (07):
  • [26] Understanding the structural and energetic basis of PD-1 and monoclonal antibodies bound to PD-L1: A molecular modeling perspective
    Shi, Danfeng
    Zhou, Shuangyan
    Liu, Xuewei
    Zhao, Chenxi
    Liu, Huanxiang
    Yao, Xiaojun
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2018, 1862 (03): : 576 - 588
  • [27] Quantification of Pharmacokinetic Profiles of PD-1/PD-L1 Antibodies by Validated ELISAs
    Zalba, Sara
    Contreras-Sandoval, Ana M.
    Martisova, Eva
    Debets, Reno
    Smerdou, Christian
    Jesus Garrido, Maria
    PHARMACEUTICS, 2020, 12 (06) : 1 - 16
  • [28] PD-1 and PD-L1 antibodies in cancer: current status and future directions
    Balar, Arjun Vasant
    Weber, Jeffrey S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (05) : 551 - 564
  • [29] Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1
    Jiang, Mengzhen
    Liu, Man
    Liu, Guodi
    Ma, Jiawen
    Zhang, Lixin
    Wang, Shenlin
    MABS, 2023, 15 (01)
  • [30] PD-1 and PD-L1 antibodies in cancer: current status and future directions
    Arjun Vasant Balar
    Jeffrey S. Weber
    Cancer Immunology, Immunotherapy, 2017, 66 : 551 - 564
12345